ThermoGenesis Holdings, Inc. (THMO) DCF Valuation

ThermoGenesis Holdings, Inc. (THMO) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

ThermoGenesis Holdings, Inc. (THMO) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate ThermoGenesis Holdings, Inc. (THMO) financial prospects like a professional! This (THMO) DCF Calculator offers pre-filled financial data and the flexibility to modify revenue growth, WACC, margins, and other crucial assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 13.0 9.7 9.3 10.5 9.4 8.8 8.2 7.7 7.1 6.7
Revenue Growth, % 0 -25.32 -4.62 12.79 -9.9 -6.76 -6.76 -6.76 -6.76 -6.76
EBITDA -4.7 -8.2 -6.6 -5.3 -7.7 -5.7 -5.3 -4.9 -4.6 -4.3
EBITDA, % -36.28 -83.75 -70.99 -50.27 -81.95 -64.65 -64.65 -64.65 -64.65 -64.65
Depreciation .8 .8 .6 .9 1.1 .7 .7 .6 .6 .6
Depreciation, % 6.18 7.74 6.81 8.83 12.14 8.34 8.34 8.34 8.34 8.34
EBIT -5.5 -8.9 -7.2 -6.2 -8.9 -6.4 -6.0 -5.6 -5.2 -4.9
EBIT, % -42.45 -91.49 -77.8 -59.11 -94.09 -72.99 -72.99 -72.99 -72.99 -72.99
Total Cash 3.2 7.2 7.3 4.2 2.0 4.2 3.9 3.6 3.4 3.2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.3 1.4 .7 1.9 .9
Account Receivables, % 9.8 14.18 7.89 17.79 10.05
Inventories 3.5 5.9 5.4 3.3 1.4 3.4 3.1 2.9 2.7 2.5
Inventories, % 26.7 60.31 57.81 31.8 14.89 38.3 38.3 38.3 38.3 38.3
Accounts Payable 1.4 1.4 1.3 .8 .9 1.0 .9 .9 .8 .8
Accounts Payable, % 11.09 14.02 13.77 7.82 10.04 11.35 11.35 11.35 11.35 11.35
Capital Expenditure -.2 .0 -.1 -.4 -1.7 -.4 -.4 -.4 -.4 -.3
Capital Expenditure, % -1.39 -0.23604 -1 -3.82 -18.35 -4.96 -4.96 -4.96 -4.96 -4.96
Tax Rate, % 4.99 4.99 4.99 4.99 4.99 4.99 4.99 4.99 4.99 4.99
EBITAT -5.2 -8.7 -6.9 -5.9 -8.4 -6.1 -5.7 -5.3 -5.0 -4.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -7.9 -10.5 -5.3 -4.9 -6.1 -7.9 -5.2 -4.9 -4.5 -4.2
WACC, % 89.36 92.43 91.02 90.67 90.28 90.75 90.75 90.75 90.75 90.75
PV UFCF
SUM PV UFCF -6.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -4
Terminal Value -5
Present Terminal Value 0
Enterprise Value -7
Net Debt 9
Equity Value -16
Diluted Shares Outstanding, MM 2
Equity Value Per Share -6.55

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real THMO financials.
  • Real-World Data: Access to historical data and forward-looking estimates (highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe how your inputs affect ThermoGenesis Holdings’ valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models tailored for ThermoGenesis Holdings, Inc. (THMO).
  • WACC Calculator: A pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
  • Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit your analysis.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to ThermoGenesis Holdings, Inc. (THMO).
  • Interactive Dashboard and Charts: Visual representations that encapsulate key valuation metrics for straightforward analysis.

How It Works

  • Download: Obtain the ready-to-use Excel file featuring ThermoGenesis Holdings, Inc. (THMO) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Generate various forecasts and instantly compare results.
  • Make Decisions: Leverage the valuation outcomes to inform your investment strategy.

Why Choose ThermoGenesis Holdings, Inc. (THMO)?

  • Innovative Solutions: Benefit from advanced technologies in cell therapy and regenerative medicine.
  • Proven Expertise: Backed by a team of professionals with extensive experience in the biotech industry.
  • Commitment to Quality: Our products meet the highest standards for safety and efficacy.
  • Customer-Centric Approach: We prioritize your needs and provide tailored support for all our clients.
  • Industry Recognition: Trusted by leading institutions and researchers worldwide.

Who Should Use This Product?

  • Healthcare Professionals: Understand advanced cellular therapies and their applications using real-world data.
  • Researchers: Integrate cutting-edge technologies into studies or clinical trials.
  • Investors: Evaluate your own strategies and assess the market potential for ThermoGenesis Holdings, Inc. (THMO).
  • Biotech Analysts: Enhance your analysis with a comprehensive, customizable model for evaluating biotech companies.
  • Entrepreneurs: Discover how established biotech firms like ThermoGenesis are positioned in the market.

What the Template Contains

  • Pre-Filled Data: Includes ThermoGenesis Holdings, Inc.'s historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze ThermoGenesis Holdings, Inc.'s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.